Difference between revisions of "CTSC:TTIC.040610"

From NAMIC Wiki
Jump to: navigation, search
Line 40: Line 40:
 
* The series has been accepted for CME credit. We will be able to offer it for the oncology session on May 21st. In the eman time we have to collect conflict of interest from all speakers. We also will have to get an evaluation form and a sign in list.
 
* The series has been accepted for CME credit. We will be able to offer it for the oncology session on May 21st. In the eman time we have to collect conflict of interest from all speakers. We also will have to get an evaluation form and a sign in list.
 
* New hands-on workshops: Bruce Fischl offered to host and run workshops on Freesurfer.
 
* New hands-on workshops: Bruce Fischl offered to host and run workshops on Freesurfer.
 +
 +
<br>
 +
 +
'''3. Multicenter trial''' <br>
 +
 +
* Bob will get a smaller group together to set up goal and agenda for the multicenter trial project.
 +
** The group will identify similar protocols already in place: pediatric MS (same neuro protocol implemented at CHB, BIDMC and MGH).
 +
**
 +
* Randy inquired the mi2b2 group whether they could help serve this project. Their question was: will the acquisitions be on clinical or research systems, will it generate an accession number?

Revision as of 00:12, 13 April 2010

Home < CTSC:TTIC.040610

Back to Collaboration:Harvard_CTSC

Agenda

  1. Consultation
  2. Education program
  3. Multi-center trial
  4. mi2b2 update


Harvard Translational Imaging Consortium Meeting Minutes April 6, 2010

In attendance:

  • Valerie Humblet
  • Randy Gollub
  • Wendy Plesniak
  • Gordon Harris
  • Charles Guttmann
  • Clare Tempany
  • Neil Rofsky
  • Jeff Yap
  • Laura Alice


1. Consultations

  • There were no new consultation this week.
  • During a meeting about the JIRA system with the IT group, Valerie asked them to evaluate if it would be possible to link request for PCIR protocol review with the creation of a new issue in JIRA.


2. Education program

  • The neuroimaging session at MGH on April 1st had a good attendance, roughly 47 people, out of 60 who registered. Valerie sent a reminder to participants the day before. She will do the same for the upcoming sessions.
  • Charles asked if we should have lectures that are more interactive, where the speaker asks questions to the audience.
  • To be added to the website: a note saying that if all seats are filled, people should contact Valerie to inquire about additional seats and/or waiting list.
  • The series has been accepted for CME credit. We will be able to offer it for the oncology session on May 21st. In the eman time we have to collect conflict of interest from all speakers. We also will have to get an evaluation form and a sign in list.
  • New hands-on workshops: Bruce Fischl offered to host and run workshops on Freesurfer.


3. Multicenter trial

  • Bob will get a smaller group together to set up goal and agenda for the multicenter trial project.
    • The group will identify similar protocols already in place: pediatric MS (same neuro protocol implemented at CHB, BIDMC and MGH).
  • Randy inquired the mi2b2 group whether they could help serve this project. Their question was: will the acquisitions be on clinical or research systems, will it generate an accession number?